Literature DB >> 2457424

Immunohistochemistry of germ cell and trophoblastic neoplasms.

G A Niehans1, J C Manivel, G T Copland, B W Scheithauer, M R Wick.   

Abstract

The immunoprofiles of 121 germ cell and trophoblastic neoplasms were defined, using a battery of antibodies against cytokeratin (CK), vimentin (VIM), epithelial membrane antigen (EMA), placental alkaline phosphatase (PLAP), S-100 protein, leukocyte common antigen (LCA), UCHL-1, LN-2, carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), chromogranin A, Leu-7, alpha-fetoprotein (AFP), alpha-1-antitrypsin (AAT), and the beta subunit of human chorionic gonadotropin (BHCG). In addition to 85 neoplasms of testicular origin, the cases included eight ovarian germ cell tumors and 28 extragonadal neoplasms. All tissues had been subjected to formalin fixation and paraffin embedding. Similar immunoreactivity patterns were seen in gonadal and extragonadal neoplasms, gestational and nongestational choriocarcinomas, components of mixed germ cell tumors and their pure counterparts, and metastatic and primary lesions. Placental alkaline phosphatase was a sensitive marker of germ cell differentiation, and expression of this marker in the absence of EMA appeared to be a staining pattern unique to germ cell tumors. Both LCA and S100 were absent in neoplastic germ cells, and thus were useful in differentiating these tumors from malignant lymphoma and malignant melanoma, respectively. Cytokeratin was helpful in distinguishing seminomas/dysgerminomas from nonseminomatous germ cell tumors, although 10% of seminomas showed focal or diffuse cytokeratin reactivity. Finally, 75% of all germ cell neoplasms displayed NSE, calling the specificity of this determinant into question.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457424     DOI: 10.1002/1097-0142(19880915)62:6<1113::aid-cncr2820620614>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  A simple method for the immunocytochemical detection of proteins inside nuclear structures that are inaccessible to specific antibodies.

Authors:  Darya M Svistunova; Yana R Musinova; Vladimir Yu Polyakov; Eugene V Sheval
Journal:  J Histochem Cytochem       Date:  2011-11-22       Impact factor: 2.479

Review 2.  Oxygenomics in environmental stress.

Authors:  H Sone; H Akanuma; T Fukuda
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  Enolase isozymes in seminoma.

Authors:  M Takashi; H Haimoto; T Nagai; T Koshikawa; K Kato
Journal:  Urol Res       Date:  1990

4.  Rete testis adenocarcinoma recurring in the inguinal lymph nodes. A case report.

Authors:  C Toklu; H Ozen; A Ergen; N Edali; O Uluoğlu
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 5.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

Review 6.  Biomarkers of disease recurrence in stage I testicular germ cell tumours.

Authors:  Peter Lesko; Michal Chovanec; Michal Mego
Journal:  Nat Rev Urol       Date:  2022-08-26       Impact factor: 16.430

7.  Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis.

Authors:  Jong-Hyuk Kim; Chi-Ho Yu; Ji-Young Yhee; Keum-Soon Im; Na-Hyun Kim; Jung-Hyang Sur
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

8.  Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors.

Authors:  Lukas Hechelhammer; Stephan Störkel; Bernhard Odermatt; Philipp U Heitz; Wolfram Jochum
Journal:  Virchows Arch       Date:  2003-06-03       Impact factor: 4.064

9.  Burned-out tumour of the testis presenting as retroperitoneal choriocarcinoma.

Authors:  J I Lopez; J C Angulo
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

10.  N-cadherin expression in malignant germ cell tumours of the testis.

Authors:  Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Peter Burfeind; Paul Thelen; Heinz-Joachim Radzun; Carl Ludwig Behnes
Journal:  BMC Clin Pathol       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.